Preferred Label : Ceftaroline;
MeSH definition : A fifth-generation cephalosporin antibacterial agent that is used to treat skin infections
caused by bacteria in adults and newborns. Ceftaroline has a 1,3-thiazolidine ring
attached to the C-7 position of its cephalosporin core.;
MeSH Hyperonym : Fosamil, Ceftaroline;
MeSH hyponym : TAK 599; TAK599; 91825, T; T-91825; T91825; PPI 0903; PPI0903;
UNII : H36Z0FHR8K;
Origin ID : D000097583;
UMLS CUI : C2001521;
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A fifth-generation cephalosporin antibacterial agent that is used to treat skin infections
caused by bacteria in adults and newborns. Ceftaroline has a 1,3-thiazolidine ring
attached to the C-7 position of its cephalosporin core.
https://www.has-sante.fr/jcms/p_3203286/fr/zinforo
2020
false
false
false
France
insurance, health, reimbursement
treatment outcome
ceftaroline fosamil
ceftaroline fosamil
anti-bacterial agents
infant, newborn
infant
complicated skin and soft tissue infection
skin diseases, bacterial
soft tissue infections
infusions, intravenous
Ceftaroline
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_2758333/fr/zinforo
https://www.has-sante.fr/portail/jcms/c_2758333/fr/zinforo-ceftaroline-cephalosporine
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
child
infant
treatment outcome
ceftaroline fosamil
ceftaroline fosamil
ceftaroline fosamil
Ceftaroline Fosamil Acetate
anti-bacterial agents
anti-bacterial agents
infusions, intravenous
skin diseases, bacterial
complicated skin and soft tissue infection
soft tissue infections
pneumonia, bacterial
community-acquired infections
Ceftaroline
Ceftaroline
---
http://www.has-sante.fr/portail/jcms/c_1362362/zinforo-ceftaroline-cephalosporine-par-voie-intraveineuse
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-02/zinforo_synthese_ct12539.pdf
2013
false
France
French
complicated skin and soft tissue infection
antibiotic therapy
Ceftaroline
infusions, intravenous
anti-bacterial agents
ceftaroline fosamil
ceftaroline fosamil
guidelines for drug use
insurance, health, reimbursement
community-acquired infections
skin diseases, infectious
skin diseases, infectious
soft tissue infections
pneumonia
treatment outcome
staphylococcal infections
methicillin resistance
Methicillin-Resistant staphylococcus aureus
Community acquired pneumonia
---
http://www.has-sante.fr/portail/jcms/c_1356125/zinforo
2012
false
France
French
complicated skin and soft tissue infection
antibiotic therapy
ceftaroline fosamil
ceftaroline fosamil
treatment outcome
ceftaroline fosamil
Ceftaroline
Ceftaroline
infusions, intravenous
soft tissue infections
skin diseases, infectious
community-acquired infections
pneumonia
anti-bacterial agents
anti-bacterial agents
acute disease
methicillin resistance
staphylococcal skin infections
adult
evaluation of the transparency committee
guidelines for drug use
clinical trials, phase iii as topic
soft tissue infections
skin diseases, infectious
cephalosporins
cephalosporins
---
https://www.ema.europa.eu/medicines/human/EPAR/Zinforo
2012
false
United Kingdom
English
French
complicated skin and soft tissue infection
antibiotic therapy
Ceftaroline
Ceftaroline
ceftaroline fosamil
adult
aged
anti-bacterial agents
anti-bacterial agents
breast feeding
cephalosporins
drug evaluation, preclinical
infusions, intravenous
penicillin resistance
pneumococcal infections
pneumonia
pregnancy
skin diseases, infectious
skin diseases, infectious
staphylococcal infections
streptococcus pneumoniae
treatment outcome
drug approval
community-acquired infections
soft tissue infections
soft tissue infections
Methicillin-Resistant staphylococcus aureus
ceftaroline fosamil
ceftaroline fosamil
drug evaluation
syndication feed
summary of product characteristics
package leaflet
---